Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
50.03
-2.29 (-4.38%)
Sep 29, 2026, 1:24 PM EDT - Market open

Pulse Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,5689301,071674103439
Market Cap Growth
200.16%-13.12%58.86%553.77%-76.50%-27.42%
Enterprise Value
3,4738431,000633109409
Last Close Price
52.3213.7317.4112.242.7714.81

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3149.032658.43--147.32309.48
PB Ratio
37.2311.549.3215.20-45.8712.30
P/TBV Ratio
38.6712.049.6616.99-14.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3068.992408.93--156.14288.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.090.080.21-33.790.32
Net Debt / Equity Ratio
-0.95-0.91-0.95-0.79-6.59-0.49
Net Debt / EBITDA Ratio
1.150.971.980.83-0.260.28
Net Debt / FCF Ratio
1.551.352.991.06-0.310.32
Asset Turnover
0.010.00--0.010.03
Quick Ratio
9.2710.2311.746.6110.223.37
Current Ratio
9.6310.5311.886.7610.394.30
Return on Equity (ROE)
-78.49%-74.45%-67.31%-200.46%-349.89%-217.33%
Return on Assets (ROA)
-44.34%-42.37%-36.70%-39.75%-54.93%-82.44%
Return on Capital Employed (ROCE)
-80.00%-88.80%-46.00%-83.10%-80.80%-137.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.15%-7.82%-5.00%-6.26%-56.73%-14.51%
FCF Yield
-1.65%-5.85%-3.40%-4.92%-45.98%-12.43%
Buyback Yield / Dilution
-7.37%-15.41%-17.41%-46.56%-21.35%-20.29%
SEC Filings: 10-K · 10-Q